arrow_back Back to App

Additional Leave for Bone Marrow or Stem Cell Donation

This Act amends the Family and Medical Leave Act (FMLA) to grant eligible employees an additional 40 hours of leave over a 12-month period specifically for activities related to bone marrow or blood stem cell donation. This new leave is separate from standard FMLA leave entitlements. Employees can use this time for pre-donation activities, the donation itself, and post-donation activities.
Key points
New Entitlement: Eligible employees are entitled to an additional 40 hours of leave per 12-month period for bone marrow or blood stem cell donation.
Supplemental Leave: This 40 hours is added to any existing FMLA leave entitlements.
Flexibility: The leave can be taken intermittently or on a reduced leave schedule.
Paid Leave Substitution: Employees may elect to substitute accrued paid vacation, personal, or sick leave for this time, but employers cannot require them to do so.
Notice Requirement: Employees must provide at least 30 days' notice for foreseeable leave, or as much notice as is practicable if the treatment date requires it to begin sooner.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3024
Sponsor: Rep. Phillips, Dean [D-MN-3]
Process start date: 2023-04-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Life Saving Leave Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_3024.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-04-28.

What are the main provisions?

Key points include:

  • New Entitlement: Eligible employees are entitled to an additional 40 hours of leave per 12-month period for bone marrow or blood stem cell donation.
  • Supplemental Leave: This 40 hours is added to any existing FMLA leave entitlements.
  • Flexibility: The leave can be taken intermittently or on a reduced leave schedule.
  • Paid Leave Substitution: Employees may elect to substitute accrued paid vacation, personal, or sick leave for this time, but employers cannot require them to do so.
  • Notice Requirement: Employees must provide at least 30 days' notice for foreseeable leave, or as much notice as is practicable if the treatment date requires it to begin sooner.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Phillips, Dean [D-MN-3].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Labor Health Family